American Medical Association (AMA) Grants Exosome Diagnostics a CPT PLA Specific to Its ExoDx® Prostate(IntelliScore) Test
in portfolio news
Exosome Diagnostics, Inc. announced today that the American Medical Association (AMA) has issued a new CPT® Proprietary Laboratory Analyses (PLA) code for its ExoDx® Prostate(IntelliScore) test. The new Code 0005U, will become effective May 1, 2017 and is specific to ExoDx Prostate(IntelliScore), abbreviated EPI.
Proprietary Laboratory Analyses (PLA) codes are a new addition to the CPT® code set approved by the AMA CPT® Editorial Panel. PLA codes are alpha-numeric CPT codes with a corresponding descriptor, for labs or manufacturers to more specifically identify their test.